const listdata = {
    asthma: [{
            catalog: "第一章",
            value: "哮喘疾病基础知识篇",
            list: [{
                    title: "哮喘的定义",
                    to: 1
                },
                {
                    title: "哮喘的流行病学",
                    to: 2
                },
                {
                    title: "哮喘的发病机制",
                    to: 3
                },
                {
                    title: "哮喘的诊断",
                    to: 4
                },
                {
                    title: "哮喘的评估",
                    to: 5
                },
                {
                    title: "哮喘的维持期治疗",
                    to: 6
                },
                {
                    title: "哮喘的急性发作期治疗",
                    to: 7
                },
            ]
        },
        {
            catalog: "第二章",
            value: "舒利迭®产品知识篇",
            list: [{
                    title: "舒利迭®产品基本信息",
                    to: 1
                },
                {
                    title: "舒利迭®准纳器方便易用，输出稳定",
                    to: 2
                },
                {
                    title: "舒利迭®哮喘治疗领域",
                    to: 3
                },
                {
                    title: "关键临床研究：",
                    to: 3
                },
                {
                    title: "- GOAL、",
                    to: 3
                },
                {
                    title: "- EXCEL、",
                    to: 4
                },
                {
                    title: "- CONCEPT、",
                    to: 5
                },
                {
                    title: "- LundBack 3年研究",
                    to: 6
                }
            ]
        },
        {
            catalog: "第三章",
            value: "舒利迭®成人哮喘|市场推广篇",
            list: [{
                    title: "舒利迭成人哮喘关键推广信息",
                    to: 1
                },
                {
                    title: "舒利迭成人哮喘市场策略",
                    to: 1
                },
                {
                    title: "舒利迭成人目标患者",
                    to: 2
                },
                {
                    title: "舒利迭成人哮喘目标科室",
                    to: 2
                },
                {
                    title: "客户分类及拜访策略",
                    to: 3
                },
            ]
        },
        {
            catalog: "第四章",
            value: "应对竞争产品篇",
            list: [{
                    title: "中国市场ICS/LABA产品",
                    to: 1
                },
                {
                    title: "信必可®关键研究解读",
                    to: 2
                },
                {
                    title: "- COSMOS",
                    to: 2
                },
                {
                    title: "- COMPASS",
                    to: 3
                },
                {
                    title: "- EuroSMART",
                    to: 4
                },
                {
                    title: "- SYGMA",
                    to: 5
                }
            ]
        },
        {
            catalog: "第五章",
            value: "APACT",
            list: [
                 {
                    title: "信必可® SMART策略既能作为控制用药， 又能充当缓解用药",
                    to: 1
                },
                {
                    title: "信必可®治疗哮喘快速起效",
                    to: 2
                },
                {
                    title: "信必可®也是ICS/LABA联合制剂，同样也能抗炎",
                    to: 3
                },
                {
                    title: "GINA指南已经将 SMART治疗策略纳入推荐治疗方案，这就是说指南已经认可信必可®SMART策略可以达到与舒利迭®ACD策略同样的哮喘控制。",
                    to: 4
                },
                {
                    title: "SYGMA研究: 我听说新英兰杂志近期发表了一篇轻度哮喘患者按需使用信必可的最新数据，达到了研究的主要终点，对于那些轻度的哮喘患者无疑又多了一种治疗方案",
                    to: 5
                }
            ]
        },
        {
            catalog: "附录",
            value: "",
            list: [{
                    title: "哮喘控制的调查问卷",
                    to: 1
                },
                {
                    title: "- 1. ACT",
                    to: 1
                },
                {
                    title: "- 2.ACQ和ACQ-5",
                    to: 2
                },
                {
                    title: "- 3.AQLQ ",
                    to: 3
                },
                {
                    title: "- 4.ATAQ",
                    to: 4
                },
                {
                    title: "哮喘相关医学名词",
                    to: 5
                },
                {
                    title: "Q＆A",
                    to: 6
                },
                {
                    title: "舒利迭®关键产品安全性信息",
                    to: 7
                }
            ]
        }
    ],
}
export default listdata;